Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $65,548 | 18 | 90.0% |
| Honoraria | $4,700 | 2 | 6.5% |
| Food and Beverage | $1,400 | 25 | 1.9% |
| Travel and Lodging | $1,207 | 10 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $22,356 | 17 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $20,064 | 1 | $0 (2018) |
| Allergan, Inc. | $13,197 | 13 | $0 (2020) |
| Gilead Sciences, Inc. | $4,300 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,172 | 3 | $0 (2023) |
| Janssen Global Services, LLC | $3,120 | 2 | $0 (2022) |
| H. Lundbeck A S | $2,500 | 1 | $0 (2021) |
| Pharmacosmos Therapeutics Inc. | $2,200 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $487.72 | 6 | $0 (2017) |
| PFIZER INC. | $215.38 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,279 | 7 | GENZYME CORPORATION ($11,699) |
| 2023 | $5,363 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,385) |
| 2022 | $4,800 | 3 | Janssen Global Services, LLC ($3,120) |
| 2021 | $4,700 | 2 | H. Lundbeck A S ($2,500) |
| 2020 | $5,225 | 1 | Allergan, Inc. ($5,225) |
| 2019 | $7,815 | 2 | Allergan Inc. ($7,600) |
| 2018 | $29,627 | 13 | SANOFI-AVENTIS U.S. LLC ($20,064) |
| 2017 | $1,045 | 22 | Otsuka America Pharmaceutical, Inc. ($487.72) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Consulting Fee | Cash or cash equivalent | $2,580.00 | General |
| Category: HIV | ||||||
| 11/27/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,972.00 | General |
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,430.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,874.19 | General |
| 11/04/2024 | GENZYME CORPORATION | CEREZYME (Biological) | Consulting Fee | Cash or cash equivalent | $1,972.00 | General |
| Category: Genetic Disease | ||||||
| 04/12/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,972.00 | General |
| 04/01/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,479.00 | General |
| 10/26/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,233.00 | General |
| 10/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,385.00 | General |
| 08/24/2023 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $860.00 | General |
| 07/27/2023 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 05/23/2023 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $860.00 | General |
| 12/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 01/06/2022 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $2,340.00 | General |
| 01/06/2022 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $780.00 | General |
| 07/14/2021 | Pharmacosmos Therapeutics Inc. | Monoferric (Drug) | Honoraria | Cash or cash equivalent | $2,200.00 | General |
| Category: Hematology | ||||||
| 01/22/2021 | H. Lundbeck A S | — | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| 12/05/2020 | Allergan, Inc. | DURYSTA (Drug) | Consulting Fee | Cash or cash equivalent | $5,225.00 | General |
| Category: GLAUCOMA | ||||||
| 07/16/2019 | Allergan Inc. | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| 06/26/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $215.38 | General |
| 12/10/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $343.35 | General |
| 12/10/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $74.73 | General |
| 12/10/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $11.08 | General |
| 10/29/2018 | GENZYME CORPORATION | LEMTRADA (Drug), AUBAGIO | Food and Beverage | In-kind items and services | $64.73 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/16/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $102.93 | General |
About Dr. Brian Solow, MD
Dr. Brian Solow, MD is a Family Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689665036.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Solow, MD has received a total of $72,854 in payments from pharmaceutical and medical device companies, with $14,279 received in 2024. These payments were reported across 55 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($65,548).
Practice Information
- Specialty Family Medicine
- Location Irvine, CA
- Active Since 11/03/2005
- Last Updated 03/29/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689665036
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $29,423
- DURYSTA (Drug) $5,225
- Biktarvy (Drug) $2,580
- Monoferric (Drug) $2,200
- CEREZYME (Biological) $1,972
- DUPIXENT (Biological) $1,430
- PRADAXA (Drug) $107.15
- ENTRESTO (Drug) $64.83
- LEMTRADA (Drug) $64.73
- Trintellix (Drug) $54.75
- ZULRESSO (Drug) $24.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Irvine
Dr. Marc Richmond, M.d, M.D
Family Medicine — Payments: $34,637
Dr. Albert Chang, M.d, M.D
Family Medicine — Payments: $19,529
Dr. Marlene Yacoob, Md, MD
Family Medicine — Payments: $18,874
Paul Mansonhing, M.d, M.D
Family Medicine — Payments: $17,583
Dr. Moonmock Oh, M.d, M.D
Family Medicine — Payments: $12,203
Dr. Robila Ashfaq, M.d, M.D
Family Medicine — Payments: $11,581